Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CSLM
Melbourne, Victoria, Australiacimspac.com ↗
- Ownership
- Private
- Employees
- ~32000
- Development stage
- Other
01
Overview
A global leader in biotechnology with a century-long history, CSL develops and markets plasma-derived therapies, recombinant proteins, vaccines (including influenza), iron deficiency treatments, nephrology therapies, and gene/cell therapies. Its portfolio includes numerous approved products for rare diseases such as hemophilia and hereditary angioedema. Recent clinical milestones include approvals for new HAE prophylaxis drugs ("garadacimab") and updated COVID vaccines ("Kostaive"). The company has commercialized the first FDA-approved gene therapy for hemophilia B ("Hemgenix"), though launch uptake has been gradual.
- Therapeutic areas
- NephrologyRare DiseasesImmunologyHematologyNeurologyInfectious Diseases
- Modalities
- Plasma-derived therapyRecombinant protein technologyCell therapyGene therapymRNA-based drugs
- Industry
- Pharma
02
Partnerships
Seattle Children’s Research Institute (stem cell gene therapies partnership—recently ended)Various academic collaborations globally
Beyond the preview
Go deeper on CSLM.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CSLM.